ArticleJACC. Case reports2025
Patent Foramen Ovale Closure in a Patient With Ventricular Storm and Arrhythmogenic Right Ventricular Cardiomyopathy.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundArrhythmogenic right ventricular cardiomyopathy (ARVC) has late clinical manifestations of right heart dysfunction, chamber dilation, and ventricular dysrhythmias. Elevated right-sided pressure and cardiac remodeling can result in late presentation of right to left interatrial shunting. CASE SUMMARY: A 70-year-old man presented with ventricular tachycardia (VT) storm and significant hypoxemia. His dysrhythmia settled with a combination of antiarrhythmic agents and a stellate ganglion block. Given the persistence of hypoxemia, which is a potential contributing factor to VT, further echocardiographic investigation diagnosed a large patent foramen ovale (PFO). After optimization of medical therapy, right heart catheterization demonstrated normal pulmonary artery pressures, and successful PFO closure with an Amplatzer device was performed. DISCUSSION: Development of right-to-left shunting with progression of ARVC is a rare late-stage complication, and its association with ventricular dysthymia has not been previously reported in the literature. This is the first case to our knowledge of PFO closure in ARVC for VT storm. TAKE-HOME MESSAGES: In advanced ARVC, right-sided chamber remodeling can result in stretching of the interatrial septum, leading to right-to-left shunting, hypoxemia, and ventricular dysrhythmia. Percutaneous PFO closure can be helpful in the management of RV failure, hypoxemia, and dysrhythmia in select patients with ARVC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.